Journal profile · Medicine, General & Internal
Annals of Medicine
ISSN 0785-3890 · eISSN 1365-2060 · TAYLOR & FRANCIS LTD · SWEDEN · Bi-monthly · Founded 1969
Annals of Medicine: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.92; JCR Q1 (journal website); fully open access; APC charged, amount not published; median 131 days to acceptance (135 articles, last 24 months); community-reported acceptance: about 25%; 1,058 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Annals of Medicine is published by TAYLOR & FRANCIS LTD and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Inflammatory Biomarkers in Disease Prognosis and Liver Disease Diagnosis and Treatment, together about 19.6% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Annals of Medicine is a peer-reviewed, open access journal publishing across Medicine and Health. The Journal considers research that spans from Translational Medicine to Clinical Practice and encourages collaboration across therapy areas. Annals of Medicine is the home for researchers dedicated to supporting medical professionals in advancing practice. The Journal considers Original Research, Review Articles, Clinical Trials, Protocols, Case Series and Commentaries. The Journal also welcomes the submission of negative and null results and reproducibility studies. Letters to the Editor are also considered and should discuss an analysis of an article previously published in Annals of Medicine. All material submitted to Annals of Medicine will be assessed by our expert team, with decisions made on the basis of scientific rigor regardless of the perceived significance of research findings. Annals of Medicine is part of our Elevate Series, which offers a concierge-level publishing experience including dedicated support from our expert in-house Editorial team and guaranteed response times of 48 hours or less. The journal welcomes submissions to the following sections: Addiction Anesthesiology Cardiology & Cardiovascular Disorders Clinical Pathology Dermatology Emergency Medicine Endocrinology Gastroenterology Geriatrics Hematology Hepatology Immunology Infectious Diseases Medical Education Medical Genetics & Genomics Nephrology Neurology Nutrition Oncology Ophthalmology Pediatrics Pharmacology Pregnancy, Childbirth & Women's Health Primary Care Psychiatry Public Health Pulmonary Medicine Physical Medicine & Rehabilitation Rheumatology Sports Medicine & Musculoskeletal Disorders Surgery Toxicology Urology Case reports are not accepted. Case series must review a minimum of 5 cases and will be considered where they provide novel insight on a disease or disease subtype. Review Articles should provide a thorough, unbiased, overview of the most up-to-date knowledge on a specific research topic or condition. They should typically offer an advance on the knowledge summarised in existing reviews in the topic area. Consideration of Review Articles is at the discretion of the Editorial Team. Letters to the Editor must undergo a presubmission check to be considered (Please see Instructions for Authors). When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they a
From the journal's Aims & Scope
Research area (LetPub): Medicine, General & Internal
Editorial board by country: 2 in mainland China (about 1%); most named United States 65, Italy 21, Spain 4, Finland 4, Saudi Arabia 4 (141 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine8.3%
- Inflammatory Biomarkers in Disease PrognosisMedicine5.7%
- Liver Disease Diagnosis and TreatmentMedicine5.6%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine5.1%
- Sepsis Diagnosis and TreatmentMedicine4.5%
- COVID-19 Clinical Research StudiesMedicine4.4%
- Lipoproteins and Cardiovascular HealthMedicine4.4%
- Venous Thromboembolism Diagnosis and ManagementMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPMCPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Index Medicus, All CML Journals, AgBiotechNet (CABI), Biocontrol News and Information (CABI), Biological Abstracts, BIOSIS Previews (Clarivate Analytics), Current Awareness in Biological Sciences, Environmental Science Database (CABI), Global Health (CABI), Index Medicus (NLM), Ornamental Horticulture (CABI), Plant Growth Regulator Abstracts (CABI), Psychological Abstracts, Research Alert, Review of Medical and Veterinary Entomology (CABI), Review of Medical and Veterinary Mycology (CABI), Tropag & Rural (CABI)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.92LetPub ·
- Impact factor (publisher) 2025
- 4.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.2Publisher website ·
- CiteScore 2026-06
- 6.3LetPub ·
- CiteScore (publisher) 2025
- 6.3Publisher website ·
- SJR 2026-06
- 1.3LetPub ·
- SJR (publisher) 2025
- 1.3Publisher website ·
- SNIP 2026-06
- 1.6LetPub ·
- SNIP (publisher) 2025
- 1.6Publisher website ·
- h-index
- 104LetPub ·
- h-index
- 165OpenAlex ·
- i10-index
- 2,895OpenAlex ·
- 2-year mean citedness
- 4.29OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.95%LetPub ·
Volume
- Articles per year
- 1,000LetPub ·
- Downloads per year (publisher)
- 3,800,000Publisher website ·
- Downloads per year (publisher) 2025
- 3,800,000Publisher website ·
Articles by year OpenAlex count · 6,306 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 705 | 705 | 408 |
| 2025 | 1,058 | 1,058 | 4,212 |
| 2024 | 519 | 519 | 5,172 |
| 2023 | 517 | 517 | 7,524 |
| 2022 | 332 | 332 | 9,372 |
| 2021 | 397 | 397 | 5,962 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
131 daysMedian, submission to acceptance · P25–P75 93 days – 233 days
- Acceptance to online
- median 16 days (135 articles)
- Submission to online
- median 147 days
- Sample
- 135 articles with submission and acceptance dates (1,985 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Acceptance rate (publisher)
- 13%Publisher website ·
- Acceptance rate (publisher) 2025
- 13%Publisher website ·
- Submission to first decision
- 2 daysPublisher website ·
- Submission to first decision 2025
- 2 daysPublisher website ·
- First decision after review
- 55 daysPublisher website ·
- First decision after review 2025
- 55 daysPublisher website ·
- Acceptance to publication
- 14 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 2,392 | Yes | CC BY, CC BY-NC | |
| OpenAlex | GBP 2,085 | — | — | |
| LetPub | GBP 2,392 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Not considered
- Case reports
Article types accepted7
- case seriesThe Journal considers Original Research, Review Articles, Clinical Trials, Protocols, Case Series and Commentaries.Length not stated
- clinical trialsThe Journal considers Original Research, Review Articles, Clinical Trials, Protocols, Case Series and Commentaries.Length not stated
- commentariesThe Journal considers Original Research, Review Articles, Clinical Trials, Protocols, Case Series and Commentaries.Length not stated
- letters to the editorLetters to the Editor are also considered and should discuss an analysis of an article previously published in Annals of Medicine.Length not stated
- original researchThe Journal considers Original Research, Review Articles, Clinical Trials, Protocols, Case Series and Commentaries.Length not stated
- protocolsThe Journal considers Original Research, Review Articles, Clinical Trials, Protocols, Case Series and Commentaries.Length not stated
- review articlesThe Journal considers Original Research, Review Articles, Clinical Trials, Protocols, Case Series and Commentaries.Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Annals of Medicine is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, not just those with…
Source ↗Publisher website ·- Peer review
Case series must review a minimum of 5 cases and will be considered where they provide novel insight on a disease or disease subtype. Model summary
Case series must review a minimum of 5 cases and will be considered where they provide novel insight on a disease or disease subtype.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- TAYLOR & FRANCIS LTD
- Country or region
- SWEDEN
- Language
- English
- Frequency
- Bi-monthly
- Founded
- 1969
- ISSN
- 0785-3890
- Electronic ISSN
- 1365-2060
- Latest issue on the website
- Volume 58, Issue 1 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Annals of Medicine
What CAS zone is Annals of Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Annals of Medicine is in Zone 2 of Medicine, and in Zone 2 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Annals of Medicine?
The latest impact factor listed by LetPub is 4.92; CiteScore 6.3, h-index 165.
How long does peer review take at Annals of Medicine?
Based on the dates recorded on 135 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 131 days (interquartile range 93–233 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 25%”; the journal's website gives an acceptance rate of 13% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Annals of Medicine in?
The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Where are the editorial board members of Annals of Medicine based?
Of the 141 board members whose country the journal's board page names, 2 (about 1%) are in mainland China; the countries named most often are United States (65), Italy (21) and Spain (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Annals of Medicine?
According to LetPub and DOAJ records, Annals of Medicine is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PMC, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Annals of Medicine open access, and what is the APC?
Annals of Medicine is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .